Xiang Luo
Clinical trials sponsored by Xiang Luo, explained in plain language.
-
New stroke treatment aims to bust clots in Hard-to-Reach vessels
Disease control Recruiting nowThis study is testing a new way to treat a specific type of stroke caused by a blockage in a medium-sized brain artery. Researchers want to see if delivering a powerful clot-busting drug directly to the blockage improves recovery and quality of life for patients. The trial will c…
Phase: PHASE2, PHASE3 • Sponsor: Xiang Luo • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New Two-Drug attack on stroke aims to halt brain damage in its tracks
Disease control Recruiting nowThis study is testing if giving a powerful new cholesterol-lowering injection (evolocumab) along with standard statin pills within 48 hours of a stroke can prevent patients from getting worse and help them recover better. It will involve about 429 people who have had a stroke cau…
Phase: PHASE2, PHASE3 • Sponsor: Xiang Luo • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Stroke imaging side effect: can a simple shot keep arteries open?
Disease control Recruiting nowThis study is testing if giving a blood-thinning medication (heparin) during a common imaging test for stroke can prevent a frequent complication where the wrist artery used for the test gets blocked. The trial will enroll 440 recent stroke patients to see if this approach is bot…
Phase: PHASE3 • Sponsor: Xiang Luo • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC